Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 3601 AL 3615

Calcium channel blockers and Parkinson's disease: a systematic review and meta-analysis

Lin J, Pang D, Li C, Ou R, Yu Y, Cui Y, Huang J, Shang H.

Ther Adv Neurol Disord. 2024 May 19;17:17562864241252713. doi: 10.1177/17562864241252713. eCollection 2024.

Midbrain dopaminergic degeneration differentially modulates primary motor cortex activity and motor behavior in hemi-parkinsonian rats

Boschen SL, Seethaler J, Wang S, Lujan WD, Silvernail JL, Carter RE, Chang SY, Lujan JL.

Res Sq [Preprint]. 2024 May 14:rs.3.rs-4365911. doi: 10.21203/rs.3.rs-4365911/v1.

LRRK2 G2019S variant is associated with transcriptional changes in Parkinson's disease human myeloid cells under proinflammatory environment

Navarro E, Efthymiou AG, Parks M, Riboldi GM, Vialle RA, Udine E, Muller BZ, Humphrey J, Allan A, Argyrou CC, Lopes KP, Münch A, Raymond D, Sachdev R, Shanker VL, Miravite J, Katsnelson V, Leaver K, Frucht S, Bressman SB, Marcora E, Saunders-Pullman R, Goate A, Raj T.

bioRxiv [Preprint]. 2024 May 31:2024.05.27.594821. doi: 10.1101/2024.05.27.594821.

Beta Burst-Driven Adaptive Deep Brain Stimulation Improves Gait Impairment and Freezing of Gait in Parkinson's Disease

Wilkins KB, Petrucci MN, Lambert EF, Melbourne JA, Gala AS, Akella P, Parisi L, Cui C, Kehnemouyi YM, Hoffman SL, Aditham S, Diep C, Dorris HJ, Parker JE, Herron JA, Bronte-Stewart HM.

medRxiv [Preprint]. 2024 Jun 27:2024.06.26.24309418. doi: 10.1101/2024.06.26.24309418.

Association Between Parkinson's Disease and Psoriasis: A Scoping Review

Metko D, Vaizman N, Mehta S, Vender R.

J Cutan Med Surg. 2024 Jan-Feb;28(1):72-73. doi: 10.1177/12034754231211344. Epub 2023 Nov 14.

Meta-analysis of the association between C9orf72 repeats and neurodegeneration diseases

Jin P, Li Y, Li Y.

J Neurogenet. 2024 Mar;38(1):1-8. doi: 10.1080/01677063.2024.2343672. Epub 2024 May 20.

Basal ganglia theta power indexes trait anxiety in people with Parkinson's disease

Swinnen BEKS, Hoy CW, Pegolo E, Matzilevich EU, Sun J, Ishihara B, Morgante F, Pereira E, Baig F, Hart M, Tan H, Sawacha Z, Beudel M, Wang S, Starr P, Little S, Ricciardi L.

medRxiv [Preprint]. 2024 Jun 5:2024.06.04.24308449. doi: 10.1101/2024.06.04.24308449.

Challenges and Future of the International Parkinson and Movement Disorder Society Prodromal Parkinson's Disease Criteria: Are We On the Right Track?

Kulcsarova K, Skorvanek M.

Mov Disord. 2024 Apr;39(4):637-643. doi: 10.1002/mds.29724. Epub 2024 Feb 4.

Foreword for The Role of Gene Therapy in Sickle Cell Disease and Parkinson's Disease

Leikin JB.

Dis Mon. 2024 Jul;70(7):101688. doi: 10.1016/j.disamonth.2024.101688. Epub 2024 Jan 24.

Genetics of Parkinson's Disease in Underrepresented Populations: New Studies Pave the Way

Gan-Or Z, Alcalay RN.

Mov Disord. 2024 Jan;39(1):1-2. doi: 10.1002/mds.29638.

Quality of life in patients with progressive supranuclear palsy: a review of literature and implications for practice

Markiewicz M, Madetko-Alster N, Alster P.

Front Neurol. 2024 Nov 20;15:1476488. doi: 10.3389/fneur.2024.1476488. eCollection 2024.

A Novel Quantitative Measure of Pharyngeal Shortening

Leonard R, Miles A, Bakker L, Allen J.

Laryngoscope. 2024 May;134(5):2121-2126. doi: 10.1002/lary.31149. Epub 2023 Nov 2.

Mitochondrial dysfunction in Parkinson's disease

Hattori N, Sato S.

J Neural Transm (Vienna). 2024 Dec;131(12):1415-1428. doi: 10.1007/s00702-024-02863-2. Epub 2024 Nov 25.

Transcriptomics of Human Brain Tissue in Parkinson's Disease: a Comparison of Bulk and Single-cell RNA Sequencing

Fiorini MR, Dilliott AA, Thomas RA, Farhan SMK.

Mol Neurobiol. 2024 Nov;61(11):8996-9015. doi: 10.1007/s12035-024-04124-5. Epub 2024 Apr 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias